Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-NH-PEG3-COOH, a conjugate of the E3 ligase ligand-linker synthesized compound, integrates a cereblon ligand based on Thalidomide and a linker employed in PROTAC technology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | Inquiry | Backorder | Backorder | |
| 100 mg | Inquiry | Backorder | Backorder |
| Description | Thalidomide-NH-PEG3-COOH, a conjugate of the E3 ligase ligand-linker synthesized compound, integrates a cereblon ligand based on Thalidomide and a linker employed in PROTAC technology. |
| In vitro | PROTACs consist of two distinct ligands linked together; one targets an E3 ubiquitin ligase, and the other targets the protein of interest. They utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| Synonyms | Thalidomide-NH-PEG3-COOH |
| Molecular Weight | 477.47 |
| Formula | C22H27N3O9 |
| Cas No. | 2375283-62-6 |
| Relative Density. | 1.417 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.